NewslettersMammary Cell NewsUncategorizedInteraction between HLA-G and NK Cell Receptor KIR2DL4 Orchestrates HER2-Positive Breast Cancer Resistance to TrastuzumabBy Justin.choi - June 23, 2021021Investigators found that the nonclassical histocompatibility antigen HLA-G desensitized breast cancer cells to trastuzumab by binding to the natural killer cell receptor KIR2DL4.[Signal Transduction and Targeted Therapy] 7992332 {7992332:C5EJY6YC} apa 50 1 163813 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/Full Article